Association of BRCA alterations with response to PARP inhibitors in metastatic c...
Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center...
30 May 2020
LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progres...
Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia
30 May 2020
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chem...
Prof Thomas Powles - Barts Cancer Institute, London, UK
29 May 2020
Prostate cancer patients receiving androgen-deprivation therapies shown to be at...
Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerla...
7 May 2020
COVID-19: The situation in Peru and managing radiotherapy patients
Dr. Gustavo Sarria – Presidente en Sociedad de Radioterapia del Peru, Lima, Peru
17 Apr 2020
Novel treatment strategies for prostate cancer: Senescence, senolytics and myelo...
Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland
9 Apr 2020
Shorter hormone therapy for prostate cancer
Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City, C...
24 Feb 2020
Micro-ultrasound for detection of clinically significant prostate cancer
Dr Davide Maffei - Humanitas University, Milan, Italy
24 Feb 2020
Revolutionising imaging with PSMA PET in prostate cancer
Dr Bernard Henk-Erik Jansen - VU University Medical Center, Amsterdam, The Nethe...
24 Feb 2020
Follow up from MRI imaging for low-grade prostate cancer
Dr Henk B. Luiting - University of Groningen, Groningen, The Netherlands
24 Feb 2020
Over-diagnosis of low-grade prostate cancer, good or bad?
Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium
24 Feb 2020
Updates in imaging for oligometastatic disease in urological cancers
Dr Tobias Maurer - University Hospital Hamburg-Eppendorf, Hamburg, Germany
24 Feb 2020
